Qingdao Baheal Medical INC.

SZSE:301015 Stock Report

Market Cap: CN¥14.2b

Qingdao Baheal Medical Balance Sheet Health

Financial Health criteria checks 6/6

Qingdao Baheal Medical has a total shareholder equity of CN¥2.5B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are CN¥5.4B and CN¥2.8B respectively. Qingdao Baheal Medical's EBIT is CN¥975.5M making its interest coverage ratio 24.2. It has cash and short-term investments of CN¥1.0B.

Key information

47.9%

Debt to equity ratio

CN¥1.21b

Debt

Interest coverage ratio24.2x
CashCN¥1.03b
EquityCN¥2.52b
Total liabilitiesCN¥2.84b
Total assetsCN¥5.36b

Recent financial health updates

Recent updates

Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

Oct 21
Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

It's Down 25% But Qingdao Baheal Medical INC. (SZSE:301015) Could Be Riskier Than It Looks

Jun 30
It's Down 25% But Qingdao Baheal Medical INC. (SZSE:301015) Could Be Riskier Than It Looks

Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns

Jun 21
Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns

Qingdao Baheal Medical (SZSE:301015) Has Affirmed Its Dividend Of CN¥0.762

May 26
Qingdao Baheal Medical (SZSE:301015) Has Affirmed Its Dividend Of CN¥0.762

Qingdao Baheal Medical (SZSE:301015) Has A Rock Solid Balance Sheet

May 21
Qingdao Baheal Medical (SZSE:301015) Has A Rock Solid Balance Sheet

Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

Mar 01
Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital

Financial Position Analysis

Short Term Liabilities: 301015's short term assets (CN¥4.4B) exceed its short term liabilities (CN¥1.9B).

Long Term Liabilities: 301015's short term assets (CN¥4.4B) exceed its long term liabilities (CN¥917.9M).


Debt to Equity History and Analysis

Debt Level: 301015's net debt to equity ratio (7%) is considered satisfactory.

Reducing Debt: 301015's debt to equity ratio has reduced from 71.9% to 47.9% over the past 5 years.

Debt Coverage: 301015's debt is well covered by operating cash flow (44%).

Interest Coverage: 301015's interest payments on its debt are well covered by EBIT (24.2x coverage).


Balance Sheet


Discover healthy companies